posted May 29, 2018, 8:58 PM by Chong Ching Wern
[
updated Jul 3, 2018, 7:55 PM by Ho Ai Wui
]
28 May 2018 (Circular No. SP PPUM: 196/2018):
The following medications will be facing supply disruptions:
|
No.
|
Name of Medication
|
Formulary Category
|
Cause / Action by Pharmacy
|
Estimated Stock Recovery
|
Alternative Medication
|
1)
|
Albumin Human 20% Injection
|
Standard Formulary |
· Production issues by Grifols Malaysia Sdn. Bhd.
· Usage is only reserved for critical cases including 'replacement after large volume parecentesis'.
|
Until further notice. |
None, other companies are also experiencing stock issues.
Please contact Inpatient Pharmacy first for elective surgeries. |
2)
|
Co-Trimoxazole 480mg Injection
|
Standard Formulary |
· Production issues by Pfizer (M) Sdn. Bhd.
· Supply limited to patients who are unable to tolerate oral therapy.
|
August 2018. |
Consider use of Co-Trimoxazole 480mg Tablet in view of its oral bio-availability is comparable to the injection. |
3)
|
Ketamine 500mg/10mL Injection |
Standard Formulary |
· Production issues by Duopharma (M) Sdn. Bhd. and Pharmaniaga Sdn. Bhd.
|
Until further notice. |
Consider use of other anaesthesias which are available in our Standard Formulary. |
4)
|
Prothrombin Complex (Factor II, VII, IX, X) Injection (Octoplex)
|
Standard Formulary |
· Stock supply issues by Pharmaniaga Marketing Sdn. Bhd. |
Early July 2018. |
None. |
5)
|
Ropivacaine 150mg/20mL Injection (Naropin) |
Standard Formulary |
· Stock supply issues by Aspen Malaysia Sdn. Bhd.
· Supply of medication will be controlled by Inpatient Pharmacy.
|
Until further notice. |
None, will notify when all stocks have been used up. |
6)
|
Dosulepin 75mg Tablet |
Standard Formulary |
· Production issues by all distributors for this medication in Malaysia.
|
Until further notice. |
Dosulepin 25mg Tablet will be used. |
7)
|
Cisplatin 50mg/50mL Injection |
Standard Formulary |
· Production issues by Pfizer (M) Sdn. Bhd. and other manufacturers.
· Sorting out supplies from companies that still have leftover stocks.
|
Until further notice. |
None, doctors are encouraged not to start new patients on this medication. |
|
|
